TMDX Q1 2024 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$97M+133.1% YoY

Gross Profit

$60M61.8% margin

Operating Income

$12M12.8% margin

Net Income

$12M12.6% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+19.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$48M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$724M

Total Liabilities

$564M

Stockholders' Equity

$159M

Cash & Equivalents

$350M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$97M	$42M	+133.1%
Gross Profit	$60M	$29M	+108.1%
Operating Income	$12M	-$2M	+694.6%
Net Income	$12M	-$3M	+562.7%

Revenue Segments

Product

$61M63%

Service

$36M37%